SK14892002A3 - Prípravok majúci mobilizačbú aktivitu - Google Patents

Prípravok majúci mobilizačbú aktivitu Download PDF

Info

Publication number
SK14892002A3
SK14892002A3 SK1489-2002A SK14892002A SK14892002A3 SK 14892002 A3 SK14892002 A3 SK 14892002A3 SK 14892002 A SK14892002 A SK 14892002A SK 14892002 A3 SK14892002 A3 SK 14892002A3
Authority
SK
Slovakia
Prior art keywords
defibrotide
csf
hematopoietic
capacity
progenitors
Prior art date
Application number
SK1489-2002A
Other languages
English (en)
Slovak (sk)
Inventor
Laura Ferro
Roberto Porta
Massimo Iacobelli
Alessandro Masimo Gianni
Carmelo Carlo Stella
Original Assignee
Gentium Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Gentium Spa filed Critical Gentium Spa
Publication of SK14892002A3 publication Critical patent/SK14892002A3/sk

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/19Cytokines; Lymphokines; Interferons
    • A61K38/193Colony stimulating factors [CSF]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06Antianaemics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
SK1489-2002A 2000-04-18 2001-04-10 Prípravok majúci mobilizačbú aktivitu SK14892002A3 (sk)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP00830293A EP1147777A1 (en) 2000-04-18 2000-04-18 Combination of defibrotide and G-CSF and its use to activate haematopoietic progenitors
PCT/EP2001/004105 WO2001078761A2 (en) 2000-04-18 2001-04-10 Mixture of defibrotide and g-csf ant its use for activating haematopoietic progenitors

Publications (1)

Publication Number Publication Date
SK14892002A3 true SK14892002A3 (sk) 2003-06-03

Family

ID=8175292

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1489-2002A SK14892002A3 (sk) 2000-04-18 2001-04-10 Prípravok majúci mobilizačbú aktivitu

Country Status (31)

Country Link
US (1) US20040131588A1 (is)
EP (3) EP1147777A1 (is)
JP (1) JP5205668B2 (is)
KR (1) KR100849491B1 (is)
CN (1) CN1183962C (is)
AT (2) ATE443524T1 (is)
AU (2) AU5832201A (is)
BG (1) BG107203A (is)
CA (1) CA2406179C (is)
CY (1) CY1104971T1 (is)
CZ (1) CZ20023426A3 (is)
DE (2) DE60140015D1 (is)
DK (2) DK1621207T3 (is)
EE (1) EE200200596A (is)
ES (2) ES2252227T3 (is)
HR (1) HRP20020835A2 (is)
HU (1) HUP0300560A3 (is)
IL (1) IL152328A (is)
IS (1) IS2171B (is)
MX (1) MXPA02010346A (is)
NO (1) NO20024988L (is)
NZ (1) NZ522016A (is)
PL (1) PL358100A1 (is)
PT (1) PT1621207E (is)
RO (1) RO121006B1 (is)
RU (1) RU2248216C2 (is)
SI (1) SI21079B (is)
SK (1) SK14892002A3 (is)
UA (1) UA73566C2 (is)
WO (1) WO2001078761A2 (is)
ZA (1) ZA200208413B (is)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8771663B2 (en) 2000-04-18 2014-07-08 Gentium Spa Formulation having mobilising activity
US7417026B2 (en) 2003-08-13 2008-08-26 Children's Hospital Medical Center Mobilization of hematopoietic cells
JP2007535479A (ja) 2003-08-13 2007-12-06 チルドレンズ ホスピタル メディカル センター GTPaseを調節するためのキメラペプチド
EP2103689A1 (en) * 2008-03-19 2009-09-23 Gentium S.p.A. Synthetic phosphodiester oligonucleotides and therapeutical uses thereof
RU2376985C1 (ru) * 2008-07-17 2009-12-27 Владислав Николаевич Ласкавый Средство для активации стволовых клеток
DK2637672T3 (en) 2010-11-12 2018-10-22 Gentium S R L DEFIBROTID FOR USE IN PROPHYLAXY AND / OR TREATMENT OF GRAPHIC VERSUS HOST DISEASE (GVHD)
MX352085B (es) 2012-06-22 2017-11-08 Gentium S R L Método a base de euglobulina para determinar la actividad biológica de defibrótido.
EP3026122A1 (en) 2014-11-27 2016-06-01 Gentium S.p.A. Cellular-based method for determining the potency of defibrotide
CN106567694A (zh) * 2016-11-14 2017-04-19 北京国泰通源技术有限公司 智能控水短节
CA3055174C (en) * 2018-01-12 2021-05-18 Cellmig Biolabs Inc. Methods for generation of cytocapsulae and cytocapsular tubes
WO2021095881A1 (ja) 2019-11-13 2021-05-20 富士フイルム株式会社 加飾フィルム、成型物、及び電子デバイス

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2154279A1 (de) * 1970-11-03 1972-05-25 Crinos Industria Farmaco Medikamente für das fibrinolytische System
IT1043823B (it) * 1970-11-03 1980-02-29 Prephar Procedimento per l estrazione di acidi nucleici da organi animali
US3899481A (en) 1970-11-03 1975-08-12 Crinos Industria Farmaco Process for the controlled partial degradation of deoxyribonucleic acid extracted from animal organs
IT1206341B (it) 1984-02-16 1989-04-14 Crinos Industria Farmaco Composizione farmaceutica per il trattamento dell'ischemia acuta del miocardio.
US4694134A (en) 1985-05-28 1987-09-15 Ajax Magnethermic Corporation Apparatus for overheating edges of skelp for the production of compression welded pipe
US5223609A (en) 1986-04-17 1993-06-29 Crinos Industria Farmacobiologica S.P.A. Process for obtaining chemically defined and reproducible polydeoxyribonucleotides
IT1190313B (it) 1986-04-17 1988-02-16 Crinos Industria Farmaco Procedimento per l'ottenimento di polidesossiribonucleotidi chimicamente definiti e riproducibili e prodotto farmacologicamente attivo risultante
IT1223322B (it) * 1987-10-23 1990-09-19 Crinos Industria Farmaco Metodo per prevenire la formazione di coaguli sanguigni nel circuito extracorporeo di apparecchi di dialisi a composizione utile per esso
JP2907447B2 (ja) * 1988-08-24 1999-06-21 中外製薬株式会社 抗血栓剤
IT1231509B (it) * 1989-09-07 1991-12-07 Crinos Industria Farmaco Composizione farmceutica ad uso topico per la terapia della fragilita' capillare.
US5199942A (en) * 1991-06-07 1993-04-06 Immunex Corporation Method for improving autologous transplantation
US5977083A (en) * 1991-08-21 1999-11-02 Burcoglu; Arsinur Method for using polynucleotides, oligonucleotides and derivatives thereof to treat various disease states
JP3021906B2 (ja) * 1992-01-28 2000-03-15 松下電器産業株式会社 電動調理機
JPH08127539A (ja) * 1994-10-31 1996-05-21 Ajinomoto Co Inc ヒトil−11を含有する末梢血幹細胞増加剤
US5856444A (en) * 1994-11-30 1999-01-05 Chugai Seiyaku Kabushiki Kaisha Thrombocytopoiesis stimulating factor
DE69733694T2 (de) * 1996-07-10 2006-07-06 Muramatsu, Takashi, Nagoya Verwendung von proteinen aus der mk familie als hämatopoietischer faktor
AU1705599A (en) * 1997-11-26 1999-06-15 Allegheny University Of The Health Sciences Methods for mobilizing hematopoietic facilitating cells and hematopoietic stem cells into the peripheral blood
US6573372B2 (en) * 1999-01-07 2003-06-03 Heska Corporation Feline immunoglobulin E molecules and compositions there of

Also Published As

Publication number Publication date
AU2001258322B2 (en) 2006-03-16
EP1276497A2 (en) 2003-01-22
ATE443524T1 (de) 2009-10-15
ES2335776T3 (es) 2010-04-05
EP1276497B1 (en) 2005-11-23
HUP0300560A3 (en) 2005-07-28
ATE310532T1 (de) 2005-12-15
SI21079B (sl) 2006-08-31
UA73566C2 (en) 2005-08-15
AU5832201A (en) 2001-10-30
ZA200208413B (en) 2003-10-17
IL152328A (en) 2009-12-24
IS2171B (is) 2006-11-15
KR100849491B1 (ko) 2008-07-31
SI21079A (sl) 2003-06-30
CZ20023426A3 (cs) 2003-05-14
CY1104971T1 (el) 2010-03-03
RU2002130719A (ru) 2004-03-27
IS6581A (is) 2002-10-14
HRP20020835A2 (en) 2005-10-31
DK1276497T3 (da) 2006-03-27
EP1621207A3 (en) 2006-11-22
EP1621207B1 (en) 2009-09-23
DE60115222T2 (de) 2006-08-10
DE60115222D1 (de) 2005-12-29
WO2001078761A3 (en) 2002-01-24
CA2406179A1 (en) 2001-10-25
ES2252227T3 (es) 2006-05-16
DE60140015D1 (de) 2009-11-05
PL358100A1 (en) 2004-08-09
WO2001078761A2 (en) 2001-10-25
EE200200596A (et) 2004-04-15
MXPA02010346A (es) 2004-09-06
EP1621207A2 (en) 2006-02-01
KR20030010603A (ko) 2003-02-05
JP5205668B2 (ja) 2013-06-05
CN1434719A (zh) 2003-08-06
NO20024988L (no) 2002-12-02
EP1147777A1 (en) 2001-10-24
BG107203A (bg) 2003-05-30
NZ522016A (en) 2004-10-29
CA2406179C (en) 2012-03-27
HUP0300560A2 (hu) 2003-06-28
RU2248216C2 (ru) 2005-03-20
US20040131588A1 (en) 2004-07-08
IL152328A0 (en) 2003-05-29
DK1621207T3 (da) 2010-02-01
JP2004500437A (ja) 2004-01-08
CN1183962C (zh) 2005-01-12
NO20024988D0 (no) 2002-10-16
PT1621207E (pt) 2009-12-28
RO121006B1 (ro) 2006-11-30

Similar Documents

Publication Publication Date Title
US8771663B2 (en) Formulation having mobilising activity
JP4727988B2 (ja) エリスロポエチンの使用
DE60103052T2 (de) Verwendung von cxcr4 antagonisten zur behandlung von krebs und autoimmunkrankheiten
Steward et al. Recombinant human granulocyte macrophage colony stimulating factor (rhGM-CSF) given as daily short infusions–a phase I dose-toxicity study
US20070258945A1 (en) G-GSF therapy as an adjunct to reperfusion therapy in the treatment of acute myocardial infarction
JP2007518769A (ja) 内皮前駆細胞の刺激並びに臓器の再生及び内臓障害の進行の抑制のための低用量エリスロポエチンの使用
SK14892002A3 (sk) Prípravok majúci mobilizačbú aktivitu
KR101192136B1 (ko) 혈액 줄기 세포의 동원에 유효한 g-csf와 plgf의조합 약제
AU2001258322A1 (en) Formulation having mobilising activity
US20160120897A1 (en) Dextran sulfate for use in mobilization of cells
US20110076247A1 (en) Agent comprising g-csf for prevention and treatment of diabetic peripheral neuropathy
KR101144687B1 (ko) G-csf 를 함유하는 선유아세포 동원제 및 창상 치료제
JPH05502667A (ja) 血小板減少症の処置方法及びそれに対し有用な医薬組成物
JP2010539136A (ja) 卒中発作を治療するためのg−csfの使用
JP2003073300A (ja) 造血前駆細胞動員増強剤

Legal Events

Date Code Title Description
FB9A Suspension of patent application procedure